Venture Certified
| 기술평가보증기업(기금) | 2020-08-06 ~ 2022-08-05 | 20200110349 | 2020-08-06 |
| 벤처투자유형 | 2022-08-06 ~ 2025-08-05 | 20220817010008 | 2020-08-06 |
| 벤처투자유형 | 2025-08-06 ~ 2028-08-05 | 20250730010017 | 2020-08-06 |
Revenue CAGR +9.1%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 0.1B | 0.1B | 0.0B |
| Operating Profit | -33.2B | -20.5B | -10.8B |
| Net Profit | -16.4B | -11.7B | -4.6B |
| Total Assets | 54.7B | 28.4B | 11.7B |
| Total Liabilities | 20.4B | 17.7B | 10.0B |
| Total Equity | 34.3B | 10.7B | 1.6B |
Operating Loss: Op. profit -33B
3 Consecutive Years of Net Loss
▲ 118.2%
▼ 111.4%
▼ 48.0%
▼ 84.7%
▲ 75.4%
| Name | Position | Role |
|---|---|---|
| 박재민 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "울산광역시 중구",
"ceo_name": "박재민",
"certificate": [
{
"cert_number": "20200110349",
"changes": "",
"disclosure_date": "2020-08-06",
"first_cert_date": "2020-08-06",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2020-08-06 ~ 2022-08-05"
},
{
"cert_number": "20220817010008",
"changes": "",
"disclosure_date": "2022-08-17",
"first_cert_date": "2020-08-06",
"no": "2",
"type": "벤처투자유형",
"valid_period": "2022-08-06 ~ 2025-08-05"
},
{
"cert_number": "20250730010017",
"changes": "",
"disclosure_date": "2025-07-30",
"first_cert_date": "2020-08-06",
"no": "3",
"type": "벤처투자유형",
"valid_period": "2025-08-06 ~ 2028-08-05"
}
],
"company_name": "주식회사 타이로스코프(THYROSCOPE INC.)",
"corp_no": "230111-*******",
"financials": {
"2022": {
"capital_stock": 23638000,
"cost_of_sales": 0,
"current_assets": 586856000,
"current_liabilities": 1003916000,
"gross_profit": 0,
"net_income": -456696000,
"net_income_bs": -456696000,
"non_current_assets": 580638000,
"non_current_liabilities": 0,
"non_operating_expenses": 17757000,
"non_operating_income": 644401000,
"operating_profit": -1083340000,
"revenue": 0,
"sga_expenses": 1083340000,
"total_assets": 1167494000,
"total_equity": 163578000,
"total_liabilities": 1003916000
},
"2023": {
"capital_stock": 26988000,
"cost_of_sales": 0,
"current_assets": 1586849000,
"current_liabilities": 996724000,
"gross_profit": 11000000,
"net_income": -1171624000,
"net_income_bs": -1171624000,
"non_current_assets": 1253715000,
"non_current_liabilities": 770306000,
"non_operating_expenses": 118527000,
"non_operating_income": 1000211000,
"operating_profit": -2053308000,
"revenue": 11000000,
"sga_expenses": 2064308000,
"total_assets": 2840564000,
"total_equity": 1073534000,
"total_liabilities": 1767030000
},
"2024": {
"capital_stock": 32985000,
"cost_of_sales": 0,
"current_assets": 3741538000,
"current_liabilities": 1121650000,
"gross_profit": 12000000,
"net_income": -1641170000,
"net_income_bs": -1641170000,
"non_current_assets": 1733050000,
"non_current_liabilities": 920555000,
"non_operating_expenses": 97734000,
"non_operating_income": 1771834000,
"operating_profit": -3315270000,
"revenue": 12000000,
"sga_expenses": 3327270000,
"total_assets": 5474588000,
"total_equity": 3432383000,
"total_liabilities": 2042205000
}
},
"industry": "응용 소프트웨어 개발 및 공급업",
"investment": [
{
"amount": "1,000,054,818",
"changes": "1,000,054,818",
"date": "2024-08-16"
},
{
"amount": "199,000,000",
"changes": "199,000,000",
"date": "2021-12-24"
},
{
"amount": "100,000,000",
"changes": "100,000,000",
"date": "2021-04-21"
},
{
"amount": "51,000,000",
"changes": "51,000,000",
"date": "2020-10-06"
}
],
"main_products": "모바일 의료용 소프트웨어",
"phone": "052-264-****",
"years": [
2024,
2023,
2022
]
}